Cargando…

Cytokine Adsorber Use during DCD Heart Perfusion Counteracts Coronary Microvascular Dysfunction

Microvascular dysfunction (MVD) in cardiac allografts is associated with an impaired endothelial function in the coronary microvasculature. Ischemia/reperfusion injury (IRI) deteriorates endothelial function. Hearts donated after circulatory death (DCD) are exposed to warm ischemia before initiating...

Descripción completa

Detalles Bibliográficos
Autores principales: Saemann, Lars, Hoorn, Fabio, Georgevici, Adrian-Iustin, Pohl, Sabine, Korkmaz-Icöz, Sevil, Veres, Gábor, Guo, Yuxing, Karck, Matthias, Simm, Andreas, Wenzel, Folker, Szabó, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687281/
https://www.ncbi.nlm.nih.gov/pubmed/36421466
http://dx.doi.org/10.3390/antiox11112280
_version_ 1784835965149249536
author Saemann, Lars
Hoorn, Fabio
Georgevici, Adrian-Iustin
Pohl, Sabine
Korkmaz-Icöz, Sevil
Veres, Gábor
Guo, Yuxing
Karck, Matthias
Simm, Andreas
Wenzel, Folker
Szabó, Gábor
author_facet Saemann, Lars
Hoorn, Fabio
Georgevici, Adrian-Iustin
Pohl, Sabine
Korkmaz-Icöz, Sevil
Veres, Gábor
Guo, Yuxing
Karck, Matthias
Simm, Andreas
Wenzel, Folker
Szabó, Gábor
author_sort Saemann, Lars
collection PubMed
description Microvascular dysfunction (MVD) in cardiac allografts is associated with an impaired endothelial function in the coronary microvasculature. Ischemia/reperfusion injury (IRI) deteriorates endothelial function. Hearts donated after circulatory death (DCD) are exposed to warm ischemia before initiating ex vivo blood perfusion (BP). The impact of cytokine adsorption during BP to prevent MVD in DCD hearts is unknown. In a porcine DCD model, we assessed the microvascular function of hearts after BP with (DCD-BP(CytoS), n = 5) or without (DCD-BP, n = 5) cytokine adsorption (CytoSorb(®)). Microvascular autoregulation was assessed by increasing the coronary perfusion pressure, while myocardial microcirculation was measured by Laser-Doppler-Perfusion (LDP). We analyzed the immunoreactivity of arteriolar oxidative stress markers nitrotyrosine and 4-hydroxy-2-nonenal (HNE), endothelial injury indicating cell adhesion molecules CD54, CD106 and CD31, and eNOS. We profiled the concentration of 13 cytokines in the perfusate. The expression of 84 genes was determined and analyzed using machine learning and decision trees. Non-DCD hearts served as a control for the gene expression analysis. Compared to DCD-BP, relative LDP was improved in the DCD-BP(CytoS) group (1.51 ± 0.17 vs. 1.08 ± 0.17). Several pro- and anti-inflammatory cytokines were reduced in the DCD-BP(CytoS) group. The expression of eNOS significantly increased, and the expression of nitrotyrosine, HNE, CD54, CD106, and CD31, markers of endothelial injury, majorly decreased in the DCD-BP(CytoS) group. Three genes allowed exact differentiation between groups; regulation of HIF1A enabled differentiation between perfusion (DCD-BP, DCD-BP(CytoS)) and non-perfusion groups. CAV1 allowed differentiation between BP and BP(CytoS). The use of a cytokine adsorption device during BP counteracts preload-dependent MVD and preserves the microvascular endothelium by preventing oxidative stress and IRI of coronary arterioles of DCD hearts.
format Online
Article
Text
id pubmed-9687281
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96872812022-11-25 Cytokine Adsorber Use during DCD Heart Perfusion Counteracts Coronary Microvascular Dysfunction Saemann, Lars Hoorn, Fabio Georgevici, Adrian-Iustin Pohl, Sabine Korkmaz-Icöz, Sevil Veres, Gábor Guo, Yuxing Karck, Matthias Simm, Andreas Wenzel, Folker Szabó, Gábor Antioxidants (Basel) Article Microvascular dysfunction (MVD) in cardiac allografts is associated with an impaired endothelial function in the coronary microvasculature. Ischemia/reperfusion injury (IRI) deteriorates endothelial function. Hearts donated after circulatory death (DCD) are exposed to warm ischemia before initiating ex vivo blood perfusion (BP). The impact of cytokine adsorption during BP to prevent MVD in DCD hearts is unknown. In a porcine DCD model, we assessed the microvascular function of hearts after BP with (DCD-BP(CytoS), n = 5) or without (DCD-BP, n = 5) cytokine adsorption (CytoSorb(®)). Microvascular autoregulation was assessed by increasing the coronary perfusion pressure, while myocardial microcirculation was measured by Laser-Doppler-Perfusion (LDP). We analyzed the immunoreactivity of arteriolar oxidative stress markers nitrotyrosine and 4-hydroxy-2-nonenal (HNE), endothelial injury indicating cell adhesion molecules CD54, CD106 and CD31, and eNOS. We profiled the concentration of 13 cytokines in the perfusate. The expression of 84 genes was determined and analyzed using machine learning and decision trees. Non-DCD hearts served as a control for the gene expression analysis. Compared to DCD-BP, relative LDP was improved in the DCD-BP(CytoS) group (1.51 ± 0.17 vs. 1.08 ± 0.17). Several pro- and anti-inflammatory cytokines were reduced in the DCD-BP(CytoS) group. The expression of eNOS significantly increased, and the expression of nitrotyrosine, HNE, CD54, CD106, and CD31, markers of endothelial injury, majorly decreased in the DCD-BP(CytoS) group. Three genes allowed exact differentiation between groups; regulation of HIF1A enabled differentiation between perfusion (DCD-BP, DCD-BP(CytoS)) and non-perfusion groups. CAV1 allowed differentiation between BP and BP(CytoS). The use of a cytokine adsorption device during BP counteracts preload-dependent MVD and preserves the microvascular endothelium by preventing oxidative stress and IRI of coronary arterioles of DCD hearts. MDPI 2022-11-17 /pmc/articles/PMC9687281/ /pubmed/36421466 http://dx.doi.org/10.3390/antiox11112280 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Saemann, Lars
Hoorn, Fabio
Georgevici, Adrian-Iustin
Pohl, Sabine
Korkmaz-Icöz, Sevil
Veres, Gábor
Guo, Yuxing
Karck, Matthias
Simm, Andreas
Wenzel, Folker
Szabó, Gábor
Cytokine Adsorber Use during DCD Heart Perfusion Counteracts Coronary Microvascular Dysfunction
title Cytokine Adsorber Use during DCD Heart Perfusion Counteracts Coronary Microvascular Dysfunction
title_full Cytokine Adsorber Use during DCD Heart Perfusion Counteracts Coronary Microvascular Dysfunction
title_fullStr Cytokine Adsorber Use during DCD Heart Perfusion Counteracts Coronary Microvascular Dysfunction
title_full_unstemmed Cytokine Adsorber Use during DCD Heart Perfusion Counteracts Coronary Microvascular Dysfunction
title_short Cytokine Adsorber Use during DCD Heart Perfusion Counteracts Coronary Microvascular Dysfunction
title_sort cytokine adsorber use during dcd heart perfusion counteracts coronary microvascular dysfunction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687281/
https://www.ncbi.nlm.nih.gov/pubmed/36421466
http://dx.doi.org/10.3390/antiox11112280
work_keys_str_mv AT saemannlars cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction
AT hoornfabio cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction
AT georgeviciadrianiustin cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction
AT pohlsabine cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction
AT korkmazicozsevil cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction
AT veresgabor cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction
AT guoyuxing cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction
AT karckmatthias cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction
AT simmandreas cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction
AT wenzelfolker cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction
AT szabogabor cytokineadsorberuseduringdcdheartperfusioncounteractscoronarymicrovasculardysfunction